XML 56 R46.htm IDEA: XBRL DOCUMENT v3.24.3
Description of Business and Basis of Presentation - Consolidated Statements Of Stockholders' Equity (Deficit) (Unaudited) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance $ (141,460) $ (44,816) $ (36,546) $ (73,238) $ (83,809) $ (58,274) $ (36,546) $ (58,274)
Distributions (453) (2,091) (2,112) (1,000) (3,495) (3,093)    
Net loss 12,657 (10,368) (5,726) 19,642 (13,095) (21,430) (3,437) (14,883)
Other comprehensive income (loss) (8) (3) (5) 17 (1) 1    
Share-based compensation 2,245 2,841 1,763 2,243 2,647 2,170    
Issuance of shares under SEPA   146            
Exercise of stock options 247 238 324     420    
Common stock repurchased   (1,511) (4,088)          
Shares issued in connection with acquisition   267 1,574          
Exchanges of Class V voting stock       (1)        
Legal Settlement - Repurchase of Shares   (128,416)            
Legal Settlement - Liabilities   41,424            
TRA liability (52) 829   1,072 (7,000) (4,802)    
Ending balance (126,824) (141,460) (44,816) (51,265) (73,238) (83,809) (126,824) (51,265)
Accumulated Deficit                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance (137,532) (31,931) (29,391) (46,393) (48,532) (44,460) (29,391) (44,460)
Net loss 10,702 (7,087) (4,161) 7,530 (5,143) (6,805)    
Share-based compensation 2,245 2,841 1,763 2,243 2,647 2,170    
Vesting of RSUs (110) (17,759) (90) (1,730) (3,932) 1,915    
Issuance of shares under SEPA   (725)            
Exercise of stock options 30 (2,549) (931)     2,043    
Shares issued in connection with acquisition   267 879          
Exchanges of Class V voting stock   3,656   (3,244) (14,419) 208    
Legal Settlement - Repurchase of Shares   (126,498)            
Legal Settlement - Liabilities   41,424            
TRA liability (52) 829   1,072 (7,000) (4,802)    
Ending balance (124,717) (137,532) (31,931) (40,522) (46,393) (48,532) (124,717) (40,522)
Total Stockholders' Deficit Attributable to biote Corp.                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance (143,150) (36,027) (29,397) (46,405) (48,538) (44,459) (29,397) (44,459)
Net loss 10,702 (7,087) (4,161) 7,530 (5,143) (6,805)    
Other comprehensive income (loss) (7) (3) (2) 8        
Share-based compensation 2,245 2,841 1,763 2,243 2,647 2,170    
Vesting of RSUs (110) (17,766) (90) (1,731) (3,933) 1,911    
Issuance of shares under SEPA   (725)            
Exercise of stock options 30 (2,550) (931)     2,040    
Common stock repurchased   (1,511) (4,088)          
Shares issued in connection with acquisition   267 879          
Exchanges of Class V voting stock   3,658   (3,246) (14,423) 208    
Legal Settlement - Repurchase of Shares   (126,500)            
Legal Settlement - Liabilities   41,424            
TRA liability (52) 829   1,072 (7,000) (4,802)    
Ending balance (130,342) (143,150) (36,027) (40,529) (46,405) (48,538) (130,342) (40,529)
Non Controlling Interest                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance 1,690 (8,789) (7,149) (26,833) (35,271) (13,815) (7,149) (13,815)
Distributions (453) (2,091) (2,112) (1,000) (3,495) (3,093)    
Net loss 1,955 (3,281) (1,565) 12,112 (7,952) (14,625)    
Other comprehensive income (loss) (1)   (3) 9 (1) 1    
Vesting of RSUs 110 17,766 90 1,731 3,933 (1,911)    
Issuance of shares under SEPA   871            
Exercise of stock options 217 2,788 1,255     (1,620)    
Shares issued in connection with acquisition     695          
Exchanges of Class V voting stock   (3,658)   3,245 14,423 (208)    
Legal Settlement - Repurchase of Shares   (1,916)            
Ending balance 3,518 1,690 (8,789) $ (10,736) $ (26,833) $ (35,271) 3,518 $ (10,736)
As Previously Reported | Accumulated Deficit                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance (137,723) (31,303) (29,391)       (29,391)  
Net loss   (6,322) (2,070)          
Share-based compensation   2,841 1,763          
Vesting of RSUs   (19,536) (155)          
Issuance of shares under SEPA   (812)            
Exercise of stock options   (2,827) (1,831)          
Shares issued in connection with acquisition   267 381          
Exchanges of Class V voting stock   4,022            
Legal Settlement - Repurchase of Shares   (126,306)            
Legal Settlement - Liabilities   41,424            
TRA liability   829            
Ending balance   (137,723) (31,303)          
As Previously Reported | Total Stockholders' Deficit Attributable to biote Corp.                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance (143,341) (35,399) (29,397)       (29,397)  
Net loss   (6,322) (2,070)          
Other comprehensive income (loss)   (3) (2)          
Share-based compensation   2,841 1,763          
Vesting of RSUs   (19,543) (155)          
Issuance of shares under SEPA   (812)            
Exercise of stock options   (2,828) (1,831)          
Common stock repurchased   (1,511) (4,088)          
Shares issued in connection with acquisition   267 381          
Exchanges of Class V voting stock   4,024            
Legal Settlement - Repurchase of Shares   (126,308)            
Legal Settlement - Liabilities   41,424            
TRA liability   829            
Ending balance   (143,341) (35,399)          
As Previously Reported | Non Controlling Interest                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance 1,690 (9,501) (7,149)       $ (7,149)  
Distributions   (2,091) (2,112)          
Net loss   (4,153) (3,740)          
Other comprehensive income (loss)     (3)          
Vesting of RSUs   19,543 155          
Issuance of shares under SEPA   958            
Exercise of stock options   3,066 2,155          
Shares issued in connection with acquisition     1,193          
Exchanges of Class V voting stock   (4,024)            
Legal Settlement - Repurchase of Shares   (2,108)            
Ending balance   1,690 (9,501)          
Noncontrolling Interest Re-allocation | Accumulated Deficit                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance 191 (628)            
Net loss   (765) (2,091)          
Vesting of RSUs   1,777 65          
Issuance of shares under SEPA   87            
Exercise of stock options   278 900          
Shares issued in connection with acquisition     498          
Exchanges of Class V voting stock   (366)            
Legal Settlement - Repurchase of Shares   (192)            
Ending balance   191 (628)          
Noncontrolling Interest Re-allocation | Total Stockholders' Deficit Attributable to biote Corp.                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance $ 191 (628)            
Net loss   (765) (2,091)          
Vesting of RSUs   1,777 65          
Issuance of shares under SEPA   87            
Exercise of stock options   278 900          
Shares issued in connection with acquisition     498          
Exchanges of Class V voting stock   (366)            
Legal Settlement - Repurchase of Shares   (192)            
Ending balance   191 (628)          
Noncontrolling Interest Re-allocation | Non Controlling Interest                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Beginning balance   712            
Net loss   872 2,175          
Vesting of RSUs   (1,777) (65)          
Issuance of shares under SEPA   (87)            
Exercise of stock options   (278) (900)          
Shares issued in connection with acquisition     (498)          
Exchanges of Class V voting stock   366            
Legal Settlement - Repurchase of Shares   $ 192            
Ending balance     $ 712